Home › Hemophilia › Indiana
Hemophilia clinical trials in Indiana
9 studies for Hemophilia are looking for participants at sites in Indiana.
Cities in Indiana
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Innovative Hematology, Inc., Indianapolis
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT05568719A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Indiana Hemophilia-Thromb Ctr, Indianapolis
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 64 · Men · Updated Sep 18, 2026 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
- Indiana Hemophilia & Thrombosis center, Indianapolis
RecruitingPhase 1/2
Ages 2 to 59 · Men · Updated Sep 11, 2026 · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Innovative Hematology, Inc., Indianapolis
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Indiana Hemophilia and Thrombosis Center, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
- Indiana Hemophilia & Thrombosis Center, Indianapolis
RecruitingObservational study
Ages 6 to 19 · All sexes · Updated Jul 2, 2026 · NCT05022459Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Innovative Hematology, Inc. (IHI), Indianapolis
RecruitingPhase 1
Ages 0 to 90 · All sexes · Updated Apr 3, 2026 · NCT05500807Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Innovative Hematology, Inc.- Site Number : 8400006, Indianapolis
RecruitingPhase 4
Ages 12 and older · All sexes · Updated Nov 18, 2025 · NCT06941870Hemlibra in Mild Hemophilia A
- Indiana Hemophila @Thrombosis Center, Indianapolis
RecruitingPhase 4
Ages 5 to 45 · Men · Updated Mar 15, 2024 · NCT04567511From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.